Experts are excitedly focused on retatrutide, a innovative treatment created by Eli Lilly, as a significant advance in body reduction . Different than many existing approaches, retatrutide is a dual -action receptor targeting both GLP-1 and GIP, hormones that influence satiety and blood sugar contr